Dr Edward Schurr Horton, MD in Boston, MA - Internal Medicine

Dr Edward Schurr Horton, MD is a Internal Medicine - Endocrinology, Diabetes & Metabolism physician based in Boston, Massachusetts. Dr Edward Schurr Horton is licensed to practice in Massachusetts (license number 77268) and his current practice location is 1 Joslin Pl, Boston, Massachusetts. He can be reached at his office (for appointments etc.) via phone at (617) 309-2400.

NPI number for Dr Edward Schurr Horton is 1003971730 and his current mailing address is 227 Summit Ave Apt W303, Brookline, Massachusetts. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1003971730.

Contact Information

	Dr Edward Schurr Horton, MD
	1 Joslin Pl, Boston, MA 02215-5306
	(617) 309-2400
	(617) 732-2572

Physician's Profile

Full Name	Dr Edward Schurr Horton
Gender	Male
Speciality	Internal Medicine - Endocrinology, Diabetes & Metabolism
Location	1 Joslin Pl, Boston, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1003971730
Provider Enumeration Date: 12/22/2006
Last Update Date: 03/29/2011

Medical Identifiers

Medical identifiers for Dr Edward Schurr Horton such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003971730	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RE0101X	Internal Medicine - Endocrinology, Diabetes & Metabolism	77268 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Edward Schurr Horton is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Edward Schurr Horton, MD 227 Summit Ave Apt W303, Brookline, MA 02446-2326 Ph: (617) 566-1129	Dr Edward Schurr Horton, MD 1 Joslin Pl, Boston, MA 02215-5306 Ph: (617) 309-2400

News Archive

Protalix BioTherapeutics' taliglucerase alfa for Gaucher disease granted French ATU

Protalix BioTherapeutics, Inc. announced today that the French regulatory authority has granted an Autorisation Temporaire d'Utilisation (ATU), or Temporary Authorization for Use, for taliglucerase alfa for the treatment of Gaucher disease. An ATU is the regulatory mechanism used by the French Health Products and Safety Agency to make non-approved drugs available to patients in France when a genuine public health need exists.

New discovery on IL-23 can lead to novel IBD treatments

A new discovery published in the April 2001 issue of Journal of Leukocyte Biology raises hope that new treatments for illnesses like Crohn's disease and ulcerative colitis are on the horizon.

Fibromyalgia prevalence is 2.1% of the general population in Germany

Researchers have determined that fibromyalgia prevalence is 2.1% of the general population in Germany. Results appearing in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology (ACR), suggest that fibromyalgia is a spectrum disorder rather than a categorical illness. Additionally, a number of fibromyalgia cases in the general population satisfy proposed criteria for physical symptom disorder—the presence of one or more physical symptoms that impair function, which cannot be explained by another clinical or psychiatric illness.

Study reports complications relating to tongue-tie procedures in babies

Complications following a procedure to treat tongue-tie in babies are occurring that can result in admission to hospital, something a University of Otago pediatrician says needs to be better understood by both health practitioners and parents.

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.

Internal Medicine Doctors in Boston, MA

Kaitlyn My-tu Lam, MBBS Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738
Kui Toh Gerard Leong, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862
Ruma Rajbhandari, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841
Alaka Ray, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066
Meghan E Sise, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862
Aaron Dickstein, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292
Dr. Felicia Elizabeth Patch, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676

Dr Edward Schurr Horton, MD - Internal Medicine in Boston, MA